SCHEDULE: Armistice Capital Discloses 9.99% Stake in Avalon Globocare

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 9.99% of Avalon Globocare Corp.'s common stock as of March 31, 2026.

Summary

• Armistice Capital, LLC, acting as the investment manager for Armistice Capital Master Fund Ltd., and Steven Boyd, the managing member of Armistice Capital, have jointly filed a Schedule 13G.
• The filing indicates beneficial ownership of 890,521 shares of Avalon Globocare Corp. common stock.
• This ownership represents 9.99% of the class of securities.
• The reporting persons acquired and hold these shares in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of significant ownership and does not inherently indicate positive or negative performance for the company itself.

Positives

• Armistice Capital, LLC and Steven Boyd have disclosed a significant ownership stake, indicating confidence or strategic interest in Avalon Globocare Corp.
• The filing confirms that the shares were acquired and are held in the ordinary course of business, suggesting a standard investment strategy rather than a hostile takeover attempt.

Negatives

• The filing does not contain any negative financial results or operational challenges for Avalon Globocare Corp. itself; it solely reports on the ownership stake of Armistice Capital.

Risks

• While not explicitly stated as a risk in this filing, a significant ownership stake by an external entity like Armistice Capital could potentially lead to future activism or influence on corporate strategy, which may or may not align with existing management's plans.
• The Master Fund, which directly holds the shares, disclaims beneficial ownership due to its investment management agreement with Armistice Capital, creating a layer of complexity in direct control attribution.

Future Outlook

The filing does not contain forward-looking statements or guidance from Avalon Globocare Corp. It solely pertains to the ownership disclosure by Armistice Capital.

Management Comments

• Armistice Capital, LLC is the investment manager of Armistice Capital Master Fund Ltd., the direct holder of the Shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. A 9.99% ownership level is often a threshold where investors may seek to influence corporate actions or prepare for further investment.

Stakeholder Impact

• Shareholders: May see increased volatility or strategic shifts in the company due to the presence of a significant institutional investor.
• Management: May need to engage with Armistice Capital regarding corporate strategy and governance.
• Creditors: No immediate impact indicated, but long-term strategic changes could affect financial stability.

Next Steps

• Monitor future filings by Armistice Capital and Steven Boyd for any changes in ownership.
• Observe Avalon Globocare Corp.'s strategic decisions and performance for potential impacts of this significant shareholder.

Key Dates

Recommendation

This filing is a disclosure of ownership and does not provide performance data for Avalon Globocare Corp. Therefore, a 'hold' recommendation is appropriate, pending further information on the company's performance and the strategic intentions of the new significant shareholder.

Keywords

Schedule 13G, Avalon Globocare Corp., Armistice Capital, LLC, Steven Boyd, Beneficial Ownership, Common Stock, SEC Filing, Investment Management